Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases

This study has been completed.
Information provided by (Responsible Party):
Yonsei University Identifier:
First received: April 25, 2011
Last updated: December 4, 2014
Last verified: December 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2014
  Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)